Back to Dividend Stocks
Johnson & Johnson (JNJ) logo
JNJ|Healthcare|Drug Manufacturers - General|$221.32|P/E 26.3|MCap 546.9B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

78/ 100Safe

JNJ's dividend appears safe and well-supported. Strengths include a 60.3% earnings payout ratio & 34.6x interest coverage. Areas of concern: Volatile profit margin stability. As a Dividend Aristocrat with 25+ consecutive years of increases, JNJ has a proven commitment to shareholders.

Based on 15 of 15 metrics

Strengths

  • Interest Coverage: 34.6xEarnings cover interest payments many times over.
  • Return on Equity: 26.4%Strong return on equity reflects efficient profit generation.
  • Operating Margin: 27.4%Healthy operating margin provides a wide buffer.

Risks

  • Profit Margin Stability: VolatileProfit margins have been volatile.

Payout & Coverage

Safe
Earnings Payout Ratio
60.3%Safe
FCF Payout Ratio
71.9%Caution
CFO Payout Ratio
55.7%Caution
Interest Coverage
34.6xVery Safe

Balance Sheet

Safe
Net Debt / Total Assets
14.2%Safe
Current Ratio
1.0xCaution
Debt-to-Equity
67.7Safe

Profitability

Safe
Return on Equity
26.4%Very Safe
Operating Margin
27.4%Very Safe
Gross Margin
66.3%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Very Safe
Dividend Streak
Aristocrat (25+ yrs)Very Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
5.3%Safe
Earnings Stability
GrowingVery Safe

About Johnson & Johnson

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, focusing on pharmaceuticals in oncology, immunology, neuroscience, and other therapeutic areas, and MedTech, encompassing medical devices in cardiovascular, orthopaedics, vision care, and electrophysiology. Key products include DARZALEX for oncology, TREMFYA for immunology, and innovative platforms like OMNYPULSE for pulsed-field ablation treatments. Founded in 1887 and headquartered in New Brunswick, New Jersey, the company employs approximately 139,800 people and generates substantial revenue, reaching $94.2 billion in the latest full year with operational growth of 5.3%, driven by a robust pipeline and R&D investments exceeding $32 billion. Johnson & Johnson maintains strong financials, including a dividend yield around 2.1% and consistent payout growth, positioning it as a Dividend King in the healthcare sector. Its diversified portfolio ensures stable cash flows, supporting global distribution through hospitals, physicians, clinics, and partners, while addressing major health challenges across consumer, business, and institutional markets.

Dividend Overview

Dividend Yield

2.29%

Annual Dividend

$5.20

Frequency

Quarterly

Payout Ratio

60.25%

FCF Payout Ratio

71.92%

Stock Price

$221.32

52-Week Range

$146.12 $251.71

Dividend History (2016–2025)

JNJ annual dividend per share and yield history

Earnings & Profitability

JNJ earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

May 26, 2026

Next Payment Date

June 9, 2026

Dividend Growth

3-Year Dividend CAGR

4.92%

5-Year Dividend CAGR

5.25%

10-Year Dividend CAGR

5.71%

3-Year Total Growth

15.51%

5-Year Total Growth

29.15%

10-Year Total Growth

74.24%

Dividend Aristocrat (25+ yrs)

This company has increased its dividend for 25+ consecutive years.

Income Calculator

JNJ Dividend Calculator

Total Investment

$22,132.00

Annual Income

$520.00

Quarterly Income

$130.00

Monthly Income

$43.33

Similar Dividend Stocks

StockYield5Y CAGRPrice
Johnson & Johnson (JNJ) logo
JNJ
2.29%5.25%$221.32
AbbVie Inc. (ABBV) logo
ABBV
3.35%6.81%$201.55
Amgen Inc. (AMGN) logo
AMGN
2.95%8.27%$331.70
Gilead Sciences Inc. (GILD) logo
GILD
2.43%3.04%$131.33
Merck & Co., Inc. (MRK) logo
MRK
2.98%6.75%$111.38
Pfizer Inc. (PFE) logo
PFE
6.70%3.59%$25.68
UnitedHealth Group Incorporated (UNH) logo
UNH
2.33%12.57%$379.98

Frequently Asked Questions

What is JNJ's current dividend yield?
Johnson & Johnson (JNJ) currently has a dividend yield of 2.29%, based on a stock price of $221.32 and an annual dividend of $5.20.
When is JNJ's next dividend payment date?
JNJ's next ex-dividend date is 2026-05-26 and the next payment date is 2026-06-09. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does JNJ pay in dividends per year?
Johnson & Johnson paid $5.14 per share in annual dividends in 2025. The dividends are paid quarterly.
Has JNJ been increasing its dividend?
Yes, Johnson & Johnson is a Dividend Aristocrat (25+ yrs). Its dividend has grown at a 5-year CAGR of 5.25%, a 3-year CAGR of 4.92% and a 10-year CAGR of 5.71%.
Is JNJ's dividend safe?
Johnson & Johnson has a payout ratio of 60.25%. Its free cash flow payout ratio is 71.92%. The payout ratio is moderate. Monitor earnings to ensure sustainability.
How is JNJ's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Johnson & Johnson's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track JNJ Dividends with OnlyDividends

What will JNJ actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.